// App-Quantinova.ai

POS0065-PARE (2021) : HEALTH IMPACT OF OVERWEIGHT AND OBESITY IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS. RESULTS FROM THE EUROPEAN MAP OF AXIAL SPONDYLOARTHRITIS (EMAS)

Researchers

Presenter

  • M. Garrido-Cumbrera

Principal Investigators

  • D. Poddubnyy

  • L. Christen

  • C. Bundy

  • R. Mahapatra

  • S. Makri

  • S. Sanz-Gomez

  • J. Correa-Fernndez

  • C. J. Delgado-Domnguez

  • V. Navarro-Compn

Medical Centers

  • Universidad de Sevilla, Health & Territory Research (HTR), Seville, Spain

  • Charité-Universitätsmedizin Berlin, Rheumatology Department, Berlin, Germany

  • Novartis Pharma AG, Patient Engagement, Basel, Spain

  • Cardiff University School of Medicine, Cardiff, United Kingdom

  • Axial Spondyloarthritis International Federation (ASIF), Patient Advocacy, London, United Kingdom

  • Cyprus League for People with Rheumatism (CYLPER), Patient Advocacy, Nicosia, Cyprus

  • Hospital Universitario La Paz, Madrid, Spain

Locations

  • Spain

  • Germany

  • Switzerland

  • United Kingdom

  • Cyprus

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

  • Endocrine/metabolic Diseases (ME)

Disease

  • Axial spondyloarthritis

  • Obesity

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Abbvie

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved